Abstract
Metabolic syndrome is defined as a combination of obesity, arterial hypertension, dyslipidemia, impaired glucose metabolism and other pathologies that in combination markedly increase cardiovascular risk. The treatment of arterial hypertension in patient with metabolic syndrome is an important part of complex lifestyle and therapeutic measures aiming at lowering total cardiovascular risk.
Increased physical activity, hypocaloric diet with sodium restriction and smoking cessation represent an integral part of lifystele measures. Pharmacological treatment of choice are ACE-inhibitors or AT1-receptor blockers in combination with calcium channel blockers combined with other antihypertensive agents such as diuretics, beta-blockers and others, if necessary.
Intensive treatment of diabetes, dyslipidemia and the intervention of other cardiovascular risk factors is another important part of complex therapeutic approach.